BRCA1 and ovarian carcinoma: It has been shown that around 10–15% of epithelial ovarian cancer (EOC) patients carry germline mutation in BRCA1 or BRCA2 with the highest incidence seen with HGSE subtypes (Manchana et al., 2019).